Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Roles of Gut Microbial Metabolites in Diabetic Kidney Disease
Qing Fang, Na Liu, Binjie Zheng, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

The Role of the Gut Microbiota in the Pathogenesis of Diabetes
Weronika Bielka, Agnieszka Przezak, Andrzej Pawlik
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 1, pp. 480-480
Open Access | Times Cited: 107
Moutan Cortex polysaccharide ameliorates diabetic kidney disease via modulating gut microbiota dynamically in rats
Meng Zhang, Licheng Yang, Maomao Zhu, et al.
International Journal of Biological Macromolecules (2022) Vol. 206, pp. 849-860
Closed Access | Times Cited: 59
New insights into the role of immunity and inflammation in diabetic kidney disease in the omics era
Xinrong Hu, Sixiu Chen, Siyang Ye, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 14
Lipid metabolism disorder in diabetic kidney disease
Yi-Zhen Han, Bo-Xuan Du, Xingyu Zhu, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 11
Phenylsulfate-induced oxidative stress and mitochondrial dysfunction in podocytes are ameliorated by Astragaloside IV activation of the SIRT1/PGC1α /Nrf1 signaling pathway
Liu Li, Junju Zou, Hui Zhou, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 117008-117008
Open Access | Times Cited: 9
The Role of Gut Microbiota and Microbiota-Related Serum Metabolites in the Progression of Diabetic Kidney Disease
Qing Zhang, Yanmei Zhang, Lu Zeng, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 46
Sodium glucose co-transporter 2 (SGLT2) inhibition via dapagliflozin improves diabetic kidney disease (DKD) over time associatied with increasing effect on the gut microbiota in db/db mice
Jiajia Wu, Yan Chen, Huinan Yang, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 18
Exercise in Diabetic Nephropathy: Protective Effects and Molecular Mechanism
Ruo-Ying Li, Liang Guo
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3605-3605
Open Access | Times Cited: 7
Molecular mechanisms of gut microbiota in diabetic nephropathy
Gang Cheng, Yulin Liu, Rong Guo, et al.
Diabetes Research and Clinical Practice (2024) Vol. 213, pp. 111726-111726
Closed Access | Times Cited: 7
Reno-protective Effects of Empagliflozin in High Fat Diet Induced Obesity-Related Glomerulopathy by Regulation of Gut-Kidney Axis
Lei Lei, Ting Zhu, Tian-Jiao Cui, et al.
AJP Cell Physiology (2024) Vol. 327, Iss. 4, pp. C994-C1011
Open Access | Times Cited: 6
A systematic review and meta-analysis of gut microbiota in diabetic kidney disease: Comparisons with diabetes mellitus, non-diabetic kidney disease, and healthy individuals
Shisheng Han, Min Chen, Cheng Pei, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 27
The role and mechanism of the gut microbiota in the development and treatment of diabetic kidney disease
Xiaofang Wu, Lei Zhao, Yújiāng Zhāng, et al.
Frontiers in Physiology (2023) Vol. 14
Open Access | Times Cited: 15
Quantitative, Targeted Analysis of Gut Microbiota Derived Metabolites Provides Novel Biomarkers of Early Diabetic Kidney Disease in Type 2 Diabetes Mellitus Patients
Lavinia Balint, Carmen Socaciu, Andreea Iulia Socaciu, et al.
Biomolecules (2023) Vol. 13, Iss. 7, pp. 1086-1086
Open Access | Times Cited: 13
Intestinal microbiota dysbiosis in acute kidney injury: novel insights into mechanisms and promising therapeutic strategies
Juan Lei, Yifan Xie, Jingyi Sheng, et al.
Renal Failure (2022) Vol. 44, Iss. 1, pp. 571-580
Open Access | Times Cited: 22
The role and mechanism of gut microbiota-derived short-chain fatty in the prevention and treatment of diabetic kidney disease
Pengyu Tao, Jing Ji, Qian Wang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 22
Abelmoschus Manihot ameliorates the levels of circulating metabolites in diabetic nephropathy by modulating gut microbiota in non‐obese diabetes mice
Ruiya Shi, Yingjun Tao, Haitao Tang, et al.
Microbial Biotechnology (2022) Vol. 16, Iss. 4, pp. 813-826
Open Access | Times Cited: 21
Depiction of Branched-Chain Amino Acids (BCAAs) in Diabetes with a Focus on Diabetic Microvascular Complications
Daniela Maria Tănase, Evelina Maria Gosav, Tina Boţoc, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 18, pp. 6053-6053
Open Access | Times Cited: 11
The impact of weight loss on renal function in individuals with obesity and type 2 diabetes: a comprehensive review
Xuemei Gong, Xiaoxi Zeng, Ping Fu
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 4
Investigating the role of gut microbiota in diabetic nephropathy through plasma proteome mediated analysis
Shaojie Fu, Fan Li, Jinyu Yu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
The pathogenic role of intestinal flora metabolites in diabetic nephropathy
En Tian, Feng Wang, Lei Zhao, et al.
Frontiers in Physiology (2023) Vol. 14
Open Access | Times Cited: 10
Role of Gut Microbiota, Immune Imbalance, and Allostatic Load in the Occurrence and Development of Diabetic Kidney Disease
Yi Han, Hui Juan Zheng, Bo Du, et al.
Journal of Diabetes Research (2023) Vol. 2023, pp. 1-17
Open Access | Times Cited: 10
Integrated 16S rRNA sequencing and metabolomic analysis reveals the potential protective mechanism of Germacrone on diabetic nephropathy in mice
Yunguang Wang, Xinxin He, Mengjiao Xue, et al.
Acta Biochimica et Biophysica Sinica (2024)
Open Access | Times Cited: 3
Innovative Treatments to Counteract Endothelial Dysfunction in Chronic Kidney Disease Patients
Giulia Marrone, Kevin Cornali, Manuela Di Lauro, et al.
Biomedicines (2024) Vol. 12, Iss. 5, pp. 1085-1085
Open Access | Times Cited: 3
Exploring the causal connection: insights into diabetic nephropathy and gut microbiota from whole-genome sequencing databases
Lin Rui, Rongping Chen
Renal Failure (2024) Vol. 46, Iss. 2
Open Access | Times Cited: 3
Gut Microbiota and Their Metabolites as Modulators of Vascular Complications in Diabetes
Meng Yun Duan, Jielu Wen, Anning Chen, et al.
(2025), pp. 2-2
Open Access
Page 1 - Next Page

Scroll to top